Edition:
United Kingdom

Innate Pharma SA (IPH.PA)

IPH.PA on Paris Stock Exchange

5.86EUR
4:35pm BST
Change (% chg)

€0.10 (+1.74%)
Prev Close
€5.76
Open
€5.73
Day's High
€5.88
Day's Low
€5.73
Volume
53,112
Avg. Vol
187,847
52-wk High
€9.44
52-wk Low
€4.41

About

Innate Pharma SA is a France-based biopharmaceutical Company that develops drugs for treatment of cancer and inflammatory diseases. The Company identifies and characterizes drug candidates, selects indications and manages the pre-clinical and clinical development of products. Innate Pharma primarily focuses on the development of... (more)

Overall

Beta: 1.11
Market Cap(Mil.): €603.39
Shares Outstanding(Mil.): 57.36
Dividend: --
Yield (%): --

Financials

  IPH.PA Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -0.14 -- --
ROI: -4.04 8.96 14.49
ROE: -10.93 10.09 15.79

Earnings vs. Estimates